Polysaccharide surface modified Fe3O4 nanoparticles for camptothecin loading and release
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Drug Transport and Resistance Mechanisms · Protein Interaction Studies and Fluorescence Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (39)
Show source-provided references
1. Nanostructured materials in solid state ionics10.1016/S0167-2738(00)00324-6 ↗
2. Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system10.1016/j.jmmm.2005.01.064 ↗
3. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake10.1016/S0142-9612(01)00267-8 ↗
4. Intracellular labeling of T-cells with superparamagnetic contrast agents10.1002/mrm.1910300513 ↗
5. Measuring transferring receptor gene expression by NMR imaging10.1016/S0167-4889(98)00002-0 ↗
6. Magnetically labeled cells can be detected by MR imaging10.1002/jmri.1880070140 ↗
7. Synthesis of oligonucleotide functionalized magnetic nanoparticles and study on their in vitro cell uptake10.1002/aoc.752 ↗
8. News focus—nanomaterials show signs of toxicity10.1126/science.300.5617.243a ↗
9. Noninvasive imaging of quantum dots in mice10.1021/bc034153y ↗
10. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo10.1126/science.1083780 ↗
11. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cell10.1021/la0503451 ↗
12. Receptor-mediated delivery of trans-retinoic acid to hepatocyte using poly (l-lactic acid) nanoparticles coated with galactose-carrying polystyrene10.1016/S0168-3659(01)00390-X ↗
13. Iron oxide nanoparticles for sustained delivery of anticancer agents10.1021/mp0500014 ↗
14. Locoregional cancer treatment with magnetic drug targeting
15. Antibody-magnetic nanoparticles: in vitro characterization of potential tumor-specific contrast agent for magnetic resonance imaging10.1021/bc00023a007 ↗
16. A novel and rapid method for quantification of magnetic nanoparticle–cell interactions using a desktop susceptometer10.1088/0957-4484/15/5/009 ↗
17. Applications of magnetic targeting in diagnosis and therapy—possibilities and limitations: a mini-review10.1089/hyb.1997.16.109 ↗
18. Drug targeting10.1016/S0928-0987(00)00166-4 ↗
19. Fussel F, Dissertation, Aachen: Rheinsch-Westfalische Technische Hochschule Aachen; 1997.
20. Protective coating of superparamagnetic iron oxide nanoparticles10.1021/cm021349j ↗
21. Chemical modification of chitosan, synthesis of organosoluble, palladium adsorbable, and biodegradable chitosan derivatives toward the chemical plating on plastics10.1021/bm0200478 ↗
22. Preparation of the well-disperse superparamagnetic iron oxide nanoparticles in an aqueous solution with biocompatible N-succinyl-O-carboxymethylchitosan10.1021/jp711319a ↗
23. Suspension of Fe3O4 nanoparticles stabilized by chitosan and O-carboxymethylchitosan10.1016/j.ijpharm.2007.09.004 ↗
24. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system10.1016/0169-409X(95)00039-A ↗
25. Specific association of thiamine-coated gadolinium nanoparticles with human breast cancer cells expressing thiamine transporters10.1021/bc0340013 ↗
26. Nanoparticles in cancer therapy and diagnosis10.1016/S0169-409X(02)00044-3 ↗
27. Preparation of the well-disperse effective loading and controlled release of camptothecin by O-carboxymethylchitosan aggregates10.1016/j.carbpol.2005.08.006 ↗
28. Interaction between O-carboxymethylchitosan and dipalmitoyl-sn-glycero-3-phosphocholine bilayer10.1016/j.biomaterials.2005.05.021 ↗
29. The aggregation behavior of O-carboxymethylchitosan in dilute aqueous solution10.1016/j.colsurfb.2005.04.009 ↗
30. Synthesis and aggregation behavior of N-succinyl-O-carboxymethylchitosan in aqueous solutions10.1007/s00396-007-1716-7 ↗
31. Incorporation and release behavior of hydrophobic drug in functionalized poly(d,l-lactide)-block-poly(ethylene oxide) micelles10.1016/j.jconrel.2003.10.012 ↗
32. Nano-engineering block copolymer aggregates for drug delivery10.1016/S0927-7765(99)00058-2 ↗
33. 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice10.1016/j.jconrel.2007.02.013 ↗
34. Characterization of protein release from photocrosslinkable hyaluronic acid–polyethylene glycol hydrogel tissue engineering scaffolds10.1016/j.biomaterials.2004.02.018 ↗
35. Structure–activity study of the actions of camptothecin derivatives on mammalian topoisomerase. I: Evidence for a specific receptor site and for a relation to antitumor activity
36. Magnetic nanoparticle design for medical, diagnosis and therapy10.1039/b402025a ↗
37. Current perspectives on the clinical experience, pharmacology and continued development of the camptothecins
38. The application of Fe3O4 nanoparticles in cancer research: a new strategy to inhibit drug resistance10.1002/jbm.a.30901 ↗
39. Effect of chitosan on the permeability of monolayers of intestinal epithelial epithelial-cells (CACO-2)10.1023/A:1018967116988 ↗